May 7, 2013
/PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced that its senior management will present at the UBS Global Healthcare Conference at
10:30 a.m. (ET)
Tuesday, May 21
New York City
The presentation by Cynosure President and CEO
and Executive Vice President, Treasurer and CFO
will be available via live and archived audio webcast accessible through a link on the
section of the Company's website,
About Cynosure, Inc.
develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, remove multi-colored tattoos, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis, reduce cellulite and treat onychomycosis.
include a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Q-switched, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, visit Cynosure's website at
Vice PresidentSharon Merrill Associates, Inc.617.542.5300
SOURCE Cynosure, Inc.